Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (392)	11/19/1998 10:39:00 PM
From: BRAVEHEART	Read Replies (1) of 1494

Hi John, I have found that technical journals are the best place to get a balanced understanding of a products or companies potential. I often read Nature Biotechnology. I will make a point of obtaining a copy of BioWorld. Thanks for the lead. However these journals rarely result in a surge in price. Usually they create a trickle effect. Over the past few weeks there has been a number of announcements and news stories on the company. Most all cite the one specific need. Some sort of funding. Sure initial funding will be good news. The real significant news will come once P. Freiman closes a partnering deal with Big Pharma. Are their any doubts that at least one of the four in negotiations will fail to partner with MERZ and NTI jointly for so many indications with such good trial results. Given the recent activity we should be easily above a buck before the leaks of a deal. This might put us at 1.75. Once the deal closes I'd expect the stock to trade between $2 and $3 per share. Then with P-2 results who knows. THE TRUTH IS THINGS ARE LOOKING GREAT Jeffrey

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next